According to dark web monitoring sources and Cybernews.com, Dexcom Inc., a California company that develops and manufactures diabetes management devices including CGMs (continuous glucose monitors), experienced a data breach allegedly carried out by the threat group known as ShinyHunters. Our firm is investigating this incident and would like to speak with people who are current or former users of Dexcom’s CGM systems, or another Dexcom product.
On or around October 1, 2026, dark web monitoring websites including Hacknotice.com detected that the cybercriminal threat group known as ShinyHunters had claimed to have breached data from Dexcom in a post made to the threat group’s dark web leak site. ShinyHunters has threatened to release the allegedly stolen files on the dark web at the end of the day on Friday, October 2, 2026, if their extortion demands are not met. ShinyHunters is a notorious threat group known for a variety of cyberattacks, including a recent data breach of FBI employees.
An October 1, 2026 article by Stefanie Schappert of Cybernews.com reported on ShinyHunters’ claims and stated that Dexcom had not responded to the publication’s request for comment. As of publication, Dexcom has not confirmed the alleged breach’s authenticity. Details of the alleged breach, such the full scope of potentially affected information and the number of potentially affected individuals, remain under investigation.
Dexcom has not confirmed that it suffered a data breach. Based on Dexcom’s business operations, including tracking patient health information sourced from CGM devices via phone apps, the following categories of information may be at risk:
Levi & Korsinsky, LLP is investigating whether potentially affected persons are entitled to compensation. If you have used Dexcom’s CGM or another Dexcom product, there is no cost or obligation to participate. Follow the link below to find out about your rights and potential legal remedies available.
Based in San Diego, California, Dexcom is a publicly traded company that specializes in diabetes management medical devices. Dexcom’s leading products are its line of continuous glucose monitoring (CGM) devices, such as the G7 and G7 CGM Systems.
UNDER THE RULES OF CERTAIN JURISDICTIONS, THIS WEBSITE MAY CONSTITUTE ATTORNEY ADVERTISING.